Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting

Ginekologia Polska

Volumn 83, Issue 10, 2012, Pages 730-736

  Mangler, Mandy ^a   Freitag, Cornelia ^a   Lanowska, Malgorzata ^a   Staeck, Oliver ^a   Schneider, Achim ^a   Speiser, Dorothee ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Breast; Breath analysis; Early Diagnosis Of Breast Cancer Cancer; Gas chromatography; Mass spectrometry (gc ms); Volatile organic compounds

Indexed keywords

EID: 84872514350     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mammographie-Screening [http://www.aerztekammerbw.de/25/ressourcen/screening.pdf]
2. Planche K, Vinnicombe S. Breast imaging in the new era. Cancer Imaging. 2004, 4, 39-50.
3. Becker N, Junkermann H. Benefit and Risk of Mammography Screening. Considerations from an Epidemiological Viewpoint. Dtsch Arztebl Int. 2008, 105, 131-136.
4. McCulloch M, Jezierski T, Broffman M, [et al.]. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther. 2006, 5, 30-39.
5. Kharitonov S, Barnes P. Exhaled biomarkers. Chest. 2006, 130, 1541-1546.
6. Chen H, Wortmann A, Zhang W, Zenobi R. Rapid in vivo fingerprinting of nonvolatile compounds in breath by extractive electrospray ionization quadrupole time-of-flight mass spectrometry. Angew Chem Int Ed Engl. 2007, 46, 580-583.
7. Dragonieri S, Schot R, Mertens B, [et al.]. An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol. 2007, 120, 856-862.
8. Lewis N. Comparisons between mammalian and artificial olfaction based on arrays of carbon black-polymer composite vapor detectors. Acc Chem Res. 2004, 37, 663-672.
9. Lembcke B, Kirchhoff S, Caspary W. Simplified methods of expiratory hydrogen (H2) analysis--clinical testing of two H2 breath test devices. Z Gastroenterol. 1983, 21, 545-549.
10. Phillips M, Boehmer J, Cataneo R, [et al.]. Prediction of heart transplant rejection with a breath test for markers of oxidative stress. Am J Cardiol. 2004, 94, 1593-1594.
11. Miekisch W, Schubert J, Noeldge-Schomburg G. Diagnostic potential of breath analysis--focus on volatile organic compounds. Clin Chim Acta. 2004, 347, 25-39.
12. Barker M, Hengst M, Schmid J, [et al.]. Koppmann Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis. Eur Respir J. 2006, 27, 929-936.
13. Chen X, Xu F, Wang Y, [et al.]. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Cancer. 2007, 110, 835-844.
14. Buszewski B, Kesy M, Ligor T, Amann A. Human exhaled air analytics: biomarkers of diseases. Biomed Chromatogr. 2007, 21, 553-566.
15. Poli D, Carbognani P, Corradi M, [et al.]. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir Res. 2005, 6, 71.
16. Phillips M, Gleeson K, Hughes J, [et al.]. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet. 1999, 353, 1930-1933.
17. Bleda-Iniesta C, de Castro Carpeño J, Carrasco J, [et al.]. New screening method for lung cancer by detecting volatile organic compounds in breath. Clin Transl Oncol. 2007, 9, 364-368.
18. Rieder J, Lirk P, Ebenbichler C, [et al.]. Analysis of volatile organic compounds: possible applications in metabolic disorders and cancer screening. Wien Klin Wochenschr. 2001, 113, 181-185.
19. Phillips M, Herrera J, Krishnan S, [et al.]. Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl. 1999, 729, 75-88.
20. Schleibinger H, Laussmann D, Brattig C, [et al.]. Emission patterns and emission rates of MVOC and the possibility for predicting hidden mold damage? Indoor Air. 2005, 5, Suppl 9, 98-104.
21. Phillips M, Cataneo R, Ditkoff B, [et al.]. Volatile markers of breast cancer in the breath. Breast J. 2003, 9, 184-191.
22. Phillips M, Cataneo R, Greenberg J, [et al.]. Increased oxidative stress in younger as well as in older humans. Clin Chim Acta. 2003, 328, 83-86.
23. Phillips M, Greenberg J, Awad J. Metabolic and environmental origins of volatile organic compounds in breath. J Clin Pathol. 1994, 47, 1052-1053.
24. Deshpande V, Kehrer J. Oxidative stress-driven mechanisms of nordihydroguaiaretic acidinduced apoptosis in FL5.12 cells. Toxicol Appl Pharmacol. 2006, 214, 230-236.
25. Thomas R, Roy D. Mitochondrial enzyme-catalyzed oxidation and reduction reactions of stilbene estrogen. Carcinogenesis. 1995, 16, 891-895.
26. Paoletti P. Application of biomarkers in population studies for respiratory non-malignant diseases. Toxicology. 1995, 101, 99-105. Review.
27. Hietanen E, Bartsch H, Béréziat J, [et al.]. Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study. Eur J Clin Nutr. 1994, 48, 575-586.
28. Weitz Z, Birnbaum A, Sobotka P, [et al.]. High breath pentane concentrations during acute myocardial infarction. Lancet. 1991, 337, 933-935.
29. Humad S, Zarling E, Clapper M, Skosey J. Breath pentane excretion as a marker of disease activity in rheumatoid arthritis. Free Radic Res Commun. 1988, 5, 101-106.
30. Moretti M, Phillips M, Abouzeid A, [et al.]. Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia. Am J Obstet Gynecol. 2004, 190, 1184-1190.